FindTrial
Sign In

To see sepsis rate in nicu

To Study Incidence and clinical outcomes of culture positive sepsis in a Level III NICU – a ambispective observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/066153
Enrollment
800
Registered
2024-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P369- Bacterial sepsis of newborn, unspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr Sonali Amol Avale
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All neonates with culture positive sepsis in NICU, Government medical College and Hospital Aurangabad from January 2021 to March 2025

Exclusion criteria

Exclusion criteria: All neonates with sterile culture reports

Design outcomes

Primary

MeasureTime frame
To study the incidence of MDR and XDR in NICUTimepoint: 4 weeks—

Secondary

MeasureTime frame
• Mortality • Duration of hospital stay • Complications during stay • CLABSI • Meningitis • VAP • NEC • ROPTimepoint: Death Discharge—

Countries

India

Contacts

Public ContactDr Laxmikant Deshmukh

Government Medical college , Sambhaji Nagar

deshmukhls@yahoo.com9822478275

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026